Elicio Therapeutics, Inc. (ELTX)
NASDAQ: ELTX · Real-Time Price · USD
4.930
-0.170 (-3.33%)
Nov 22, 2024, 4:00 PM EST - Market closed

Elicio Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Market Capitalization
5380----
Enterprise Value
5372----
Last Close Price
4.938.34----
PB Ratio
-2.857.04----
P/TBV Ratio
-7.04----
Debt / Equity Ratio
-1.370.610.84-2.880.030.13
Quick Ratio
2.881.320.900.494.533.90
Current Ratio
3.401.671.560.554.674.15
Return on Equity (ROE)
--346.95%-1170.93%-430.76%-136.60%-
Return on Assets (ROA)
-73.70%-89.70%-79.16%-92.36%-68.96%-
Return on Capital (ROIC)
-192.46%-128.82%-123.12%-130.00%-80.83%-
Earnings Yield
-88.30%-43.93%----
FCF Yield
-72.13%-40.89%----
Buyback Yield / Dilution
-30.44%-1500.08%97.93%-42.39%-172.21%-
Total Shareholder Return
-30.44%-1500.08%97.93%-42.39%-172.21%-
Source: S&P Capital IQ. Standard template. Financial Sources.